Objective: To investigate the relationship between indices of zinc nutritive status and biochemical markers of bone turnover in older adult European subjects. Design: Use of baseline data from a multicentre prospective zinc intervention (ZENITH) study. Setting: Centres in France, Italy and Northern Ireland. Participants: A total of 387 healthy adults, aged 55-87 y. Methods: Zinc intake was assessed by 4-day recall records. Circulating and urinary biochemical zinc status measures were assessed by atomic absorption spectrophometry. Serum bone-specific alkaline phosphatase and osteocalcin were assessed by ELISA and urinary pyridinoline (Pyr) and deoxypyridinoline (Dpyr) by HPLC. Results: Zinc intake was negatively correlated with urinary Pyr and Dpyr (r ¼ À0.298 and À0.304, respectively; Po0.0001), but was not correlated with bone formation markers. There was a tendency for serum zinc to be negatively correlated with urinary Dpyr (r ¼ À0.211; P ¼ 0.080). Erythrocyte zinc was negatively correlated with serum osteocalcin (r ¼ À0.090; Po0.0001). None of the other correlations were significant. After adjustment for confounder (age, gender and research centre) the only significant association that remained was between serum osteocalcin and erythrocyte zinc (b ¼ À0.124; P ¼ 0.011). Conclusions: There was some, albeit inconsistent, evidence of a relationship between zinc nutritive status and bone turnover in the older adult participants of the ZENITH study.
Introduction
Zinc plays an important role in nucleic acid synthesis, transcription and translation as a cofactor for some of the enzymes involved and may, therefore, participate in a broad range of metabolic activities in bone (Cashman & Flynn, 1998) . Zinc has also been shown to be required by enzymes that have specific functions in bone metabolism (Cashman & Flynn, 1998) . Both alkaline phosphatase (EC 3.1.3.1), which is required for bone calcification, and collagenase (EC 3.4.24. 3), which is required for bone resorption and remodelling (Swann et al, 1981) , are zinc metallo-enzymes.
The skeleton is a major body store of zinc and in humans approximately 30% of total body zinc is found in bone (Moser-Veillon, 1995) , probably bound to hydroxyapatite (Sauer & Wuthier, 1990) . The concentration of zinc in bone is higher than that in most tissues and is lowered quickly by zinc depletion (Calhoun et al, 1974) . Therefore, it is not surprising that defects in skeletal development have been reported in man due to zinc deficiency (Hurley, 1981) and also in acrodermatitis enteropathica, an inherited congenital disorder of zinc absorption (Hambidge et al, 1972) . It has been reported that forearm bone mineral content is correlated with zinc intake in premenopausal women, suggesting a possible role for zinc in the maintenance of bone mass (Angus et al, 1988) . Studies in humans have shown that zinc intake decreases with age, especially in women (Greger, 1977; Wagner et al, 1980) . An inverse correlation between zinc intake and bone loss in postmenopausal women was observed by Freudenheim et al (1986) . Some researchers have found an elevated urinary zinc excretion in osteoporotic women when compared to their age-matched controls (Herzberg et al, 1990; Szathmari et al, 1993; Relea et al, 1995) ; however, this may be related to increased bone resorption (Relea et al, 1995) leading to liberation of bone-bound zinc. More recently, Lowe et al (2002) reported that plasma zinc concentrations (as well as fractional zinc absorption) of osteoporotic elderly women were significantly (Po0.05) lower than that of young women.
Neither of the studies which investigated the relationship between zinc intake/status and bone mass (Freudenheim et al, 1986; Angus et al, 1988) have included indices of bone turnover. The rate of bone turnover is an important predictor of adult bone mineral density (BMD), and an increased loss of BMD has been associated with an increased rate of bone turnover (Cashman & Ginty, 2003) . Therefore, the objective of the present work was to investigate, using baseline data, the relationship between indices of zinc nutritive status and bio chemical markers of bone turnover in older adult European subjects (aged 55-87 y) participating in the ZENITH project (described throughout this supplemental issue).
Subjects and methods

Subjects
Participants were recruited via a number of means in four research centres located in three European countries. Middleaged adults, aged 55-70 y, were recruited in two of the centres, Coleraine, Northern Ireland (n ¼ 93), and Clermont-Ferrand, France (n ¼ 95). Older participants, aged 70-87 y, were recruited in Rome, Italy (n ¼ 108), and Grenoble, France (n ¼ 91). Approximately equal numbers of males and females were recruited in each centre (see Table 1 ). More comprehensive details on the subjects, including their recruitment, screening and inclusion/exclusion criteria, are provided elsewhere in this supplemental issue . Ethical approval was obtained by all four research centres from the respective ethical committees (see Polito et al, 2005) .
Design
The ZENITH study was a multicentre prospective 6-month zinc intervention study in older European adults (aged 55-87 y), which employed a randomized double-blind design. The present work only describes investigations of the relationships between markers of bone turnover and indices of zinc nutritive status in these older European adults at baseline.
Collection and preparation of samples Blood was collected by venepuncture into a vacutainer tube with no additive and processed to serum, which was immediately stored at À801C until required for analysis. Subjects were supplied with suitable collection containers for urine samples and asked to collect morning void urine samples. Portions of urine were stored at À201C from the morning of collection until required for analysis.
Experimental techniques Serum osteocalcin. Osteocalcin levels were measured in serum samples using an ELISA (Metra TM Osteocalcin EIA Kit, Quidel Corporation, CA, USA). The intra-and inter-assay CV was 6.0 and 7.6%, respectively.
Serum bone-specific alkaline phosphatase. Bone-specific alkaline phosphatase activity was measured in serum samples using an ELISA (Metrat Osteocalcin EIA Kit, Quidel Corporation, CA, USA). The intra-and inter-assay CV was 5.0 and 5.9%, respectively.
Urinary creatinine. Creatinine was determined in urine samples using a diagnostic kit (Metrat Creatinine Assay Kit, catalogue no. 8009, Quidel Corporation, CA, USA). The intra-and inter-assay CV was 1.6 and 3.3%, respectively.
Urinary pyridinoline and deoxypridinoline. Samples were analysed in duplicate using an automated analysis system (Gilson ASPEC (Automated Sample Preparation with Extraction Columns); Gilson S.A., Villiers-le-Bel, France) as described previously (Doyle et al, 2005) . The intra-assay CV for pyridinoline (Pyr) and deoxypyridinoline (Dpyr), measured as the variation between ten chromatograms obtained between column regenerations as described by Colwell et al (1993) , was 5 and 3%, respectively. The inter-assay CV for Pyr and Dpyr was 9 and 11%, respectively.
Statistical analysis
Data for all variables were not normally distributed and near-normal data distributions could not be achieved
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European Journal of Clinical Nutrition following various transformations. Therefore, the relationship between various biochemical markers of bone turnover, between various indices of zinc nutritive status, and between biochemical markers of bone turnover and indices of zinc nutritive status were investigated using Spearman's correlations. The relationships between age and biochemical measures of bone turnover were also investigated using Spearman's correlations. Differences between biochemical measures of bone turnover between genders and among research centres were investigated using Mann-Whitney and Kruskal-Wallis tests, respectively. The relationships between biochemical markers of bone turnover and indices of zinc nutritive status were also investigated using multiple regression analysis so as to control for possible confounding effects of age, gender and research centre. A P-value o0.05 was considered significant, whereas a P-value between 0.05 and 0.10 was considered representative of a trend towards significance.
Results
The mean concentrations of serum osteocalcin and bonespecific alkaline phosphatase, and of urinary Pyr and Dpyr in all ZENITH subjects, and stratified by centre and gender are shown in Table 1 . There were significant (Po0.05-0.001) gender differences in all four biochemical markers of bone turnover, where men had lower levels of all four bone markers than women. There were also significant (Po0.001) and variable differences in biochemical markers of bone metabolism between centres.
The relationships between the two markers of bone formation (serum osteocalcin and bone-specific alkaline phosphatase), and between the two markers of bone resorption (urinary Pyr and Dpyr) , and between the various markers of bone formation and bone resorption are shown in Table 2 . As expected, there was a positive correlation (Po0.05) between serum osteocalcin and bone-specific alkaline phosphatase, and a strong positive correlation (Po0.0001) between urinary Pyr and Dpyr. There were positive correlations between serum osteocalcin and both urinary Pyr (Po0.05) and Dpyr (Po0.01). There were also positive correlations between serum bone-specific alkaline phosphatase and both urinary Pyr (Po0.0001) and Dpyr (Po0.0001).
The relationships between biochemical markers of bone turnover and indices of zinc nutritive status are shown in Table 3 . Zinc intake was negatively correlated (Po0.0001) with urinary Pyr and Dpyr, but was not correlated (P40.16) with serum osteocalcin or bone-specific alkaline phosphatase. Serum zinc concentration was not correlated (P40.15) with serum osteocalcin or bone-specific alkaline phosphatase, or with urinary Pyr levels. There was a tendency (P ¼ 0.080) for serum zinc concentrations to be negatively correlated with urinary Dpyr. Erythrocyte zinc concentrations were not correlated (P40.27) with serum bone-specific alkaline phosphatase, or with urinary Pyr or Dpyr. Erythrocyte zinc concentration was negatively correlated (Po0.0001) with serum osteocalcin. Urinary zinc was positively correlated (Po0.01) with serum osteocalcin, and tended to be positively correlated (P ¼ 0.091) with urinary Pyr, but not (P40.13) with serum bone-specific alkaline phosphatase or urinary Dpyr levels.
There were significant differences in biochemical markers of bone turnover between men and women, and between research centres (Table 1 ). In addition, serum osteocalcin was positively associated with age (r ¼ 0.347; Po0.0001; n ¼ 384). There was a tendency for urinary Pyr (r ¼ À0.086; P ¼ 0.091; n ¼ 384) and Dpyr (r ¼ À0.088; P ¼ 0.086; n ¼ 384) and serum bone-specific alkaline phosphatase (r ¼ À0.097; P ¼ 0.06; n ¼ 378) to be negatively correlated with age. Therefore, the relationships between biochemical markers of bone turnover and indices of zinc nutritive status were further investigated using multiple regression analysis so as to control for possible confounders. Inclusion of age, gender and research centre in the regression analysis showed that zinc intake was no longer associated with urinary Pyr or Dpyr (data not shown). Similarly, inclusion of age, gender and research centre in the regression analysis showed that urinary zinc was no longer associated with serum osteocalcin (data not shown). However, the relationship between serum osteocalcin and erythrocyte zinc concentrations remained (b ¼ À0.124; P ¼ 0.011), even after controlling for age, gender and research centre.
Discussion
In the present study, the two markers of bone formation, and the two markers of bone resorption, were significantly and positively correlated with each other. This is to be expected as they are indices of the same cellular processes within bone metabolism. The markers of bone formation were also correlated with the markers of bone resorption, which is reflective of the fact that the two cellular processes are coupled within normal bone remodelling (Cashman & Ginty, 2003) . Therefore, the bone turnover process in the older European adults participating in the ZENITH study appeared to be normal and there was no evidence of pathological decoupling of the processes of bone formation and bone resorption.
The indices of zinc nutritive status (namely, zinc intake and biochemical status measures) in the older European adults in the present study, as discussed in more detail by Andriollo-Sanchez et al (2005) , were, in general, relatively good and there was a low prevalence of zinc deficiency (B5-6%) in this population. Zinc intake was positively correlated with urinary zinc as well as with serum zinc levels. In contrast, erythrocyte zinc was not correlated with the other indices of zinc nutritive status. Erythrocyte zinc, in comparison to serum zinc, is a marker of more long-term zinc status and less likely to be influenced by recent changes in zinc status.
Zinc intake was negatively correlated with urinary Pyr and Dpyr (sensitive and specific markers of bone resorption; Cashman & Ginty, 2003) in the older European adults in the present study. Serum zinc tended to be negatively correlated with urinary Dpyr in the present work. An increased rate of bone resorption arising from lower zinc intake/status might explain the reported inverse correlation between zinc intake and bone loss in postmenopausal women (Freudenheim et al, 1986) . There is also some evidence that zinc deficiency may be a contributory factor to bone loss associated with diabetes. Arreola et al (1990) have found that decreased serum zinc was associated with bone loss observed in poorly controlled insulin-dependent diabetic patients. In addition, zinc has been shown to inhibit osteoclastic activity and to stimulate bone formation in vitro (Moonga & Dempster, 1995) . However, the two markers of bone formation (namely, serum osteocalcin and bone-specific alkaline phosphatase; sensitive and specific markers of bone formation; Cashman & Ginty, 2003) were not correlated with zinc intake, or with serum zinc in the present study and bone resorption and bone formation appeared to be coupled. Furthermore, when potential confounding factors, such as age, gender and research centre, were included in the regression model, the apparent relationship between zinc intake and both urinary Pyr and Dpyr disappeared. Thus, it is likely that zinc intake was not related to bone turnover in these older European adults. Urinary zinc was positively correlated with serum osteocalcin in the older European adults in the present study. Some researchers have found an elevated urinary zinc excretion in osteoporotic women when compared to their age-matched controls (Herzberg et al, 1990; Szathmari et al, 1993; Relea et al, 1995) . However, whether a causal relationship between urinary zinc and bone loss exists has yet to be defined. An increased urinary zinc level may be related to increased liberation of bone-bound zinc, arising from an increased rate of bone resorption/ turnover in older adults. In the present study, the apparent relationship between urinary zinc intake and serum osteocalcin (considered by some as an index of the overall process of bone turnover as opposed to just bone formation: Cashman & Ginty, 2003) disappeared when potential confounding factors, such as age, gender and research centre, were accounted for. Erythrocyte zinc remained negatively associated with serum osteocalcin, even after these possible confounding factors were accounted for, suggesting a possible relationship between long-term zinc status and the rate of bone turnover in older adults. It is worth noting again, however, that erythrocyte zinc was not associated with the other markers of bone turnover. It is not clear why such inconsistent associations between markers of bone metabolism and indices of zinc nutritive status were evident in the present study, but it may relate to the quite variable nature of some of the biochemical markers of bone turnover, especially urinary Pyr and Dpyr (Hannon & Eastell, 2000) , which may have limited our ability to detect relationships with zinc status.
In conclusion, there was some, albeit inconsistent, evidence of a relationship between nutritive zinc status and bone turnover in the older adult participants of the ZENITH study. However, these are still only associations and the issue of causality remains to be clarified. In addition, the participants were generally healthy older adults with quite good zinc status, which may not be representative of this age group in the general population within certain European countries. Within the ZENITH multi-centre prospective 6-month zinc intervention study, which employs a randomized double-blind design, we will be able to more directly assess the influence of altering zinc intake, and presumably therefore zinc status, on the rate of bone turnover in these older European adults. The only other intervention study that investigated the effect of zinc on bone metabolism was a recent study by Nielsen & Milne (2004) . In this study, in which dietary zinc and copper intakes were altered in a factorial design, serum bone-specific alkaline phosphatase levels were unaffected but urinary levels of N-telopeptides of type I collagen (another biochemical marker of bone resorption: Cashman & Ginty, 2003) in postmenopausal women were, somewhat surprisingly, significantly increased on increasing zinc intake from 3 to 53 mg/d, irrespective of copper intake (Nielsen & Milne, 2004) , raising some safety concerns. Thus, the ZENITH study will help us advance our understanding of the role of zinc in bone health in the older adult age-group.
